Toggle navigation
Home
Search
Services
Blog
Contact
About
Z3950 Implementation Corporate Software Inc
Rubenstein, Michael
Corporate Software, Inc., Arlington, VA, United States
Search 7 grants from Michael Rubenstein
Search grants from Corporate Software, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Developmental Genetic Epidemiology of Smoking
Utility of Teledentistry to Reduce Oral Disease Burden in Preschool Children
A Randomized, Placebo-Controlled, Double-Blind, Two Period Crossover Pilot Study
Outcome Modifying Genes in Sickle Cell Disease
Retroviruses as Probes for Development
Recently added grants:
Role of KAT5 in lung cancer
Psychological and brain mechanisms underlying disparities in opioid and non-opioid pain treatment decisions
Single-molecule analysis of eukaryotic transcription activation
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV
Reduction of intracochlear fibrosis and bacterial infection using photopolymerized durable zwitterionic coatings on cochlear implant biomaterials
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Library of Medicine (NLM)
Type
Research and Development Contracts (N01)
Project #
N01LM043537-003
Application #
3664659
Study Section
Project Start
1994-08-25
Project End
1995-08-24
Budget Start
1995-08-23
Budget End
1995-08-24
Support Year
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Corporate Software, Inc.
Department
Type
DUNS #
City
Arlington
State
VA
Country
United States
Zip Code
22209
Related projects
NIH 1995
N01 LM
Z3950 Implementation Corporate Software Inc
Rubenstein, Michael / Corporate Software, Inc.
NIH 1994
N01 LM
Z3950 Implementation Corporate Software Inc
Rubenstein, Michael / Corporate Software, Inc.
Comments
Be the first to comment on Michael Rubenstein's grant